Sign in to view content

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema

Victor Hugo Gonzalez, MD

Video
Published 2024

Related

Inflammatory and Infectious Diseases Symposium
Annual Meeting Talks
2020
Diabetic Retinal Telescreening Program in a High-Risk Population Highlights Significant Rates of Retinal Pathology
Matthew P. Ohr, MD
Annual Meeting Talks
2020
Severe Vision Loss After Intravitreal Injections of Autologous Adipose Tissue-derived Stem Cells for Age-Related Macular
Ajay E Kuriyan, MD, MS
Updates from the Field
2016

Category: Diabetic Retinopathy

See more